Comparison of intravenous adrenomedullin with atrial natriuretic peptide in patients with congestive heart failure
Hideo Oya(Chiba University), Kunio Miyatake(National Cerebral and Cardiovascular Center), Norifumi Nakanishi(National Cerebral and Cardiovascular Center), Kenji Kangawa(National Cerebral and Cardiovascular Center), Shinichi Furuichi(Chiba University), Kazuyuki Ueno(Toyama Prefectural Central Hospital), Masakazu Yamagishi, Noritoshi Nagaya(National Cerebral and Cardiovascular Center), Toshio Nishikimi(Kyoto University)
Cited by 31
Related Papers
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
Semiquantitative grading of severity of mitral regurgitation by real-time two-dimensional Doppler flow imaging technique
|Journal of the American College of Cardiology|1986|573
The role of natriuretic peptides in cardioprotection
|Cardiovascular Research|2005|483
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
|Journal of Clinical Investigation|1994|478